OPK: Opko Health Inc Instablogs

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, April 24, 9:08 AM Prolor Biotech (PBTH), will be acquired by OPKO Health (OPK) in an all-stock deal worth $480M. PBTH shareholders will get 0.9551 shares of OPK for every share of PBTH they own, equating to $7 per share as of Tuesday's closing prices. PBTH +10.65% premarket. (Previously: strategic alternative evaluation boosts Prolor) 2 Comments [M&A, On the Move]
Thursday, March 7, 8:58 AM RXi Pharmaceuticals (RXII.OB) raises a gross $16.4M in a private placement led by OPKO Health (OPK) and Frost Gamma Investments Trust, which is controlled by Teva Chairman Phillip Frost. RXi issues 113M shares at $0.145 each, the same as yesterday's closing price. The firm will also acquire substantially all of OPKO's RNAi-related assets in exchange for 50M shares, as well as milestone and royalty payments. Comment! [Healthcare]
Friday, February 8, 6:09 PM OPKO Health (OPK -4.7%) finished the day markedly lower, but off its lows after responding to statements regarding the sale of company stock by Adam Logal, it's vice president, chief accounting officer and treasurer. The company notes that no other officer has exercised options or sold any shares of company stock during the last 12 months and that the sale by Logal was done to address pressing family circumstances. No other sales by insiders are being contemplated. 2 Comments [Healthcare]
Tuesday, January 29, 9:10 AM Premarket gainers: KERX +18%. PLXT +10%. VLO +8%. OPK +7%. HES +7%. RPRX +6%. AKS +6%.
Losers: OXF -24%. ANAC -23%. VMW -19%. LXK -6%. RBS -6%. STX -6%. EDU -5%. Comment! [On the Move]
Thursday, January 24, 9:10 AM Premarket gainers: NFLX +39%. SWFT +15%. ERJ +11%. NEWL +9%.
Losers: MLNX -19%. NOK -10%. ESI -10%. AAPL -10%. LOGI -9%. KMT -7%. URRE -6%. CRUS -6%. ALTR -5%. FIO -5%. VRNG -5% . OPK -5% . Comment! [On the Move]
Wednesday, January 23, 5:15 PM OPKO Health (OPK) is down in late trade after announcing a private offering to sell around $150M in convertible senior notes maturing in 2033. The notes will be listed as senior unsecured obligations and will rank equally with all of OPK's existing senior unsecured debt. Shares -6% AH. 4 Comments [Healthcare]
Thursday, December 27, 2012, 1:04 PM Drugmaker and diagnostics firm Opko Health (OPK +0.5%) acquires Brazilian pharmaceutical company Silcon Comercio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos Ltda. The acquisition represents an important strategic move for OPK's diagnostic business. It permits the commercialization of its prostate cancer test in the region while the company obtains local approval to market its point of care microfluidics disposable test cassettes. Comment! [Healthcare, Global & FX, M&A]
Wednesday, August 22, 2012, 3:52 PM Opko Health (OPK +1.6%) has been awarded a NASA contract to implement its Claros-1 point-of-care diagnostic platform for use on the International Space Station. OPK will provide a panel of assays, including Vitamin D for bone metabolism, immune health, and inflammation to be used on its portable analyzer. 1 Comment [Healthcare, On the Move]
Monday, July 16, 2012, 10:12 AM Opko Health (OPK -0.2%) appoints Juan Rodriguez as CFO to replace the retiring Rao Uppaluri. Rodriguez has over 20 years of financial and business leadership experience, over half of which is in life sciences. Most recently, Rodriguez was a consultant to German software firm Cognitec. (PR) Comment! [Healthcare]
Thursday, July 5, 2012, 1:58 PM "There's a bull/bear war brewing over Opko Health (OPK -0.4%)," writes SA author Alberto Savrieno, due to due conflicting opinions over whether billionaire CEO Phillip Frost knows what he's doing in buying shares in the company. Savrieno cites Opko's product pipeline and partnerships as reasons for optimism, but notes that it doesn't have much cash. Comment! [Quick Ideas, Healthcare]
Thursday, December 1, 2011, 9:00 AM Premarket gainers: LAVA +25%. TSPT +17%. AMR +12%. AGO +11%. YHOO +4%. LCC +5%. GMCR +3%. CLWR +3%. ALU +3%. SPIL +3%. OPK +3%.
Losers: STNG -19%. LULU -13%. KSS -7%. IRE -5%. JASO -5%. BCS -3%. Comment! [On the Move]
Friday, November 11, 2011, 7:44 AM Shares of Opko Health (OPK) rack up a 5.7% gain premarket after Jefferies initiates coverage with a Buy rating and $8 price target. Analysts point to the firm's diversified portfolio as a driver for "significant upside opportunities." Comment! [On the Move, Healthcare]
Friday, October 14, 2011, 9:15 AM Premarket gainers: CLWR +10%. GOOG +8%. S +8%. OPK +7%. GLUU +7%. HOV +6%. SWKS +6%. ADBE +5%. BIDU +5%. ERIC +5%. GMCR +5%. ALU +5%. COOL +4%. AMR +4%. RFMD +4%. RENN +4%. SOL +4%. TQNT +4%. HAL +4%. WLT +4%. MT +4%. FCX +4%. SINA +3%. AONE +3%. SIRI +3%. UN +3%. ING +3%. NFLX +3%. MU +3%. F +3%.
Losers: DEPO -24%. NCMI -23%. AVII -4%. MAT -3%. Comment! [On the Move]
Thursday, October 13, 2011, 8:58 AM Opko Health (OPK) announces the acquisition of Claros Diagnostics for an undisclosed amount in a move its CEO says will provide "near-term commercialization possibilities" from the use of the firm's microfluidics technology. Comment! [M&A]
Thursday, August 11, 2011, 10:22 AM If it's true that nobody knows a company better than the people running it, then there's hope that stocks are near the bottom, as insiders at 50 companies bought shares during Aug. 3-9, the most since the five days ended March 9, 2009. Among buyers this week were execs at HUN, WMS, CNA, CNL, NYX, CELG, OPK, KSU, GM, AKS. 1 Comment

OPK Opko Health Inc

OPK

Opko Health Inc